Puma Biotechnology
PBYI
PBYI
117 hedge funds and large institutions have $356M invested in Puma Biotechnology in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 44 increasing their positions, 43 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
4% less funds holding
Funds holding: 122 → 117 (-5)
27% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 15
Holders
117
Holding in Top 10
–
Calls
$726K
Puts
$569K
Top Buyers
| 1 | +$9.38M | |
| 2 | +$3.63M | |
| 3 | +$2.2M | |
| 4 |
FAM
Fred Alger Management
New York
|
+$2.05M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.57M |
Top Sellers
| 1 | -$4.49M | |
| 2 | -$2.77M | |
| 3 | -$2.45M | |
| 4 |
Axa
Paris,
France
|
-$1.85M |
| 5 |
DM
Deerfield Management
New York
|
-$1.85M |